Back to search

Article

Integrated Analysis of p53 Immunohistochemical Expression and TP53 Sequencing for Prognostic Assessment of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy

2026-08-26

Abstract excerpt

<h4>Background: </h4> The prognostic significance of p53 immunohistochemical expression in triple-negative breast cancer (TNBC) remains controversial, particularly following neoadjuvant chemotherapy (NAC). Whether integrating p53 immunohistochemistry with TP53 mutational analysis provides additional prognostic information has not been fully established. This study evaluated the relationship between p53 expression,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a4e03a7b-4596-5abe-97fc-9335f9f7f6b1
DOI
10.20944/preprints202608.1874.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated Analysis of p53 Immunohistochemical Expression and TP53 Sequencing for Prognostic Assessment of Triple Negative Breast Cancer After Neoadjuvant ChemotherapyDOI 10.20944/preprints202608.1874.v1
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing.Semantic proximity
P53 immunohistochemistry is an ideal surrogate marker for TP53 mutation and a predictor of early metastasis in breast cancer: Real-world analysisSemantic proximity
Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple‐negative breast cancerSemantic proximity
Subclonal evolution in the mutational landscape of early Triple negative breast cancer (TNBC) on multi-agent chemotherapy: Comparison of Pre- And Post-Neoadjuvant Chemotherapy (NAC) Samples Of TNBC Patients With Residual DiseaseSemantic proximity
Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple-negative breast cancerSemantic proximity
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerSemantic proximity
Clinical implications of molecular heterogeneity in triple negative breast cancer.Semantic proximity
Comparative analysis of mutational patterns in triple negative breast cancer before and after neoadjuvant chemotherapy in patients with residual disease.Semantic proximity
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance.Semantic proximity
Favorable prognostic impact in loss of TP53 and PIK3CA mutations after neoadjuvant chemotherapy in breast cancer.Semantic proximity
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancerSemantic proximity
The clonal and mutational evolution spectrum of primary triple-negative breast cancers.Semantic proximity
Select a neighboring publication to make it the new centre.